Avalo Therapeutics, Inc. (AVTX)

NASDAQ: AVTX · Real-Time Price · USD

15.00

-0.07 (-0.46%)

At close: Feb 18, 2026, 4:00 PM EST

14.84

-0.16 (-1.07%)

After-hours: Feb 18, 2026, 7:49 PM EST

Avalo Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 18, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	278	78	7	47	191	4,212
Market Cap Growth	217.36%	965.79%	-84.63%	-75.15%	-95.47%	-77.67%
Enterprise Value	167	-1	-1	52	153	4,180
Last Close Price	15.00	7.43	9.10	1209.61	4895.96	7603.14
PS Ratio	1446.31	176.29	3.79	2.63	35.37	628.78
PB Ratio	2.92	0.58	1.00	-4.35	8.27	171.49
P/TBV Ratio	3.43	0.63	-	-	22.11	491.62
EV/Sales Ratio	867.86	-	-	2.87	28.36	624.03
Debt / Equity Ratio	0.01	0.01	0.26	-1.98	1.53	0.06
Net Debt / Equity Ratio	-1.21	-1.00	-0.75	-0.78	-0.83	-0.71
Net Debt / EBITDA Ratio	1.68	3.28	0.24	-0.28	0.24	0.38
Net Debt / FCF Ratio	2.13	2.72	0.18	-0.32	0.27	0.43
Asset Turnover	0.00	0.01	0.07	0.32	0.09	0.17
Inventory Turnover	-	-	-	896.21	2444.83	2074.05
Quick Ratio	14.00	19.42	1.64	0.68	2.99	1.53
Current Ratio	14.28	19.95	1.82	0.74	3.11	1.71
Return on Equity (ROE)	-174.79%	-50.06%	-	-684.77%	-354.08%	-282.65%
Return on Assets (ROA)	-37.18%	-29.75%	-53.91%	-32.95%	-82.82%	-74.02%
Return on Invested Capital (ROIC)	-	-6834.61%	-	-4261.92%	-1501.54%	-367.18%
Return on Capital Employed (ROCE)	-56.80%	-28.40%	-143.20%	-266.10%	-136.20%	-165.80%
Earnings Yield	-35.90%	-45.18%	-432.43%	-87.80%	-44.19%	-1.51%
FCF Yield	-18.82%	-63.10%	-422.75%	-56.58%	-37.19%	-0.96%
Buyback Yield / Dilution	-450.90%	-2599.19%	-608.45%	-8.32%	-41.86%	-28.52%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q